Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Downgrades HLS Therapeutics to Market Perform

Raymond James downgrades HLS Therapeutics (OTC:HLTRF) from Outperform to Market Perform.

byBenzinga Newsdesk

August 6, 2021

1 minute read

Raymond James downgrades HLS Therapeutics (OTC:HLTRF) from Outperform to Market Perform.

Loop Capital Is Bullish On GMS, Sees Notable Upside

By Akanksha Bakshi

Today, 5:22 AM

GMS Inc (NYSE:GMS) was initiated by Loop Capital analyst Jeffrey Stevenson, with a Buy rating and a price target of $62, implying…

GMS

Allegion Q4 Adj EPS $1.60 Beats $1.38 Estimate, Sales $861.50M Beat $848.69M Estimate

By Benzinga Newsdesk

Today, 5:22 AM

Allegion (NYSE:ALLE) reported quarterly adjusted earnings of $1.60 per share which beat the analyst consensus estimate of $1.38 by 15.94 percent. This is a 44.14 percent increase over earnings of $1.11 per share from the

ALLE

Baird Maintains Outperform on MongoDB, Lowers Price Target to $205

By Benzinga Newsdesk

Today, 5:22 AM

Baird analyst William Power maintains MongoDB (NASDAQ:MDB) with a Outperform and lowers the price target from $330 to $205.

MDB

JMP Securities Initiates Coverage On LegalZoom.com with Market Outperform Rating, Announces Price Target of $48

By Benzinga Newsdesk

Today, 5:22 AM

JMP Securities analyst Ronald Josey initiates coverage on LegalZoom.com (NASDAQ:LZ) with a Market Outperform rating and announces Price Target of $48.

Raymond James Downgrades HLS Therapeutics to Market Perform

Related Posts

Loop Capital Is Bullish On GMS, Sees Notable Upside

Allegion Q4 Adj EPS $1.60 Beats $1.38 Estimate, Sales $861.50M Beat $848.69M Estimate

Baird Maintains Outperform on MongoDB, Lowers Price Target to $205

JMP Securities Initiates Coverage On LegalZoom.com with Market Outperform Rating, Announces Price Target of $48